Talk to our breast care nurses
0808 800 6000
Baroness Delyth Morgan, Chief Executive of Breast Cancer Now, said: While we’ve known for some time that HRT increases the risk of breast...
Baroness Delyth Morgan, Chief Executive of Breast Cancer Now, said, It’s is deeply concerning that 40% of charity-funded early career...
Mia Rosenblatt, Associate Director of Policy and Influencing at Breast Cancer Now, said: “We are very concerned that often there can be...
The Scottish Medicines Consortium (SMC) has today (9 November 2020) approved: Trastuzumab emtansine (Kadcyla) for routine NHS use in Scotland...
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “It is cause for great concern that almost half (48%) of the people...
NHS England cancer waiting times data from August 2020 shows: The two week wait target for people referred with suspected breast cancer was not...
The plasmaMATCH trial which investigates whether simple blood tests known as ‘liquid biopsies’ can benefit women with breast cancer by tracking...
A study from the University of Basal has suggested that lack of oxygen supply to a cancer tumour might encourage cells to break away from the primary...
The Scottish Medicines Consortium (SMC) has today (7 September 2020) approved Perjeta – given in combination with trastuzumab and chemotherapy...
Stay in touch
We’d love to keep in touch about news, events and how you can get involved. To hear from us, enter your email address below.
Connect with us
